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Purpose: The aim of this cross-sectional study was to investigate concentrations of cartilage and bone
markers, and pro-inﬂammatory cytokines in synovial ﬂuid (SF) collected at different time-points from
acutely injured knees with hemarthrosis and to compare these with SF concentrations of knees of age
and gender-matched healthy reference subjects.
Methods: SF was aspirated from the acutely injured knee of 111 individuals (mean age 27 years, span
13e64 years, 22% women). Concentrations of sulfated glycosaminoglycan (sGAG) were measured by
Alcian blue precipitation whereas cartilage ARGS, bone biomarkers [osteocalcin (OCL), secreted
protein acidic and rich in cysteine (SPARC) and osteopontin (OPN)] and pro-inﬂammatory cytokines
[interleukin (IL)-1b, IL-6, IL-8 and tumor necrosis factor (TNF)-a] were analyzed using electro-
chemiluminescence. Samples were also analyzed with regard to time between injury and aspiration
[same day (n ¼ 29), 1 day (n ¼ 31), 2e3 days (n ¼ 19), 4e7 days (n ¼ 20) and 8e23 days (n ¼ 12)].
Results: SF concentrations of ARGS (P < 0.001), SPARC (P < 0.001), OPN (P < 0.001), and all cytokines
(P < 0.001), but not sGAG (P ¼ 0.06) or OCL (P ¼ 0.992), were signiﬁcantly higher in injured knees
compared to knees of reference subjects. The cartilage markers sGAG and ARGS were signiﬁcantly higher
in knees aspirated later than 1 day after injury, whereas concentrations of SPARC and OPN and all
cytokines were higher in knees aspirated the same day as the injury and at all time-points thereafter.
Conclusions: Our results suggest that an acute knee injury is associated with an instant local biochemical
response to the trauma, which may affect cartilage and bone as well as the inﬂammatory activity.
 2012 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Anterior cruciate ligament (ACL) injury is a common and severe
knee injury, where typically strong forces are involved in the
trauma mechanism. The risk of developing knee osteoarthritis (OA)
as a result of acute knee injury is high1,2, and trauma induced
biochemical processes of the injured joint may have an impact on
the initiation of the OA process1,3.
Increased synovial ﬂuid (SF) markers of type II collagen and
aggrecan turnover, as well as increased concentrations of catabolic
enzymes, have been shown at various phases after joint injury4e7.
In addition, elevated levels of pro-inﬂammatory cytokines have
been detected up to 1 year after ACL injury4,8. In a cross-sectional
study of 34 acute ACL injured patients, the highest SF levels ofo: P. Swärd, Department of
, Sweden. Tel: 46-733405666.
s Research Society International. Pinﬂammatory cytokines were detected within 24 h from injury9.
However, details on the biochemical turnover over the ﬁrst month
after knee injury are largely unknown and there are no longitudinal
analyses yet available in the literature.
At least 50% of acutely ACL injured knees suffer from an asso-
ciated depression fracture, and basically all (98%) have post-trau-
matic bone marrow lesions (BML), a strong indicator of impaction
forces10. Thus, MRI ﬁndings indicate that common soft tissue knee
injuries without radiographic evidence of fractures might actually
involve injury to the subchondral bone and bone marrow.
Osteopontin (OPN)and secretedprotein acidic and rich in cysteine
(SPARC, also known as osteonectin) are matricellular proteins highly
expressed in bone matrix that do not have any structural properties
and can modulate both matrix metalloprotease (MMP) and growth
factor activities11,12. In adults, these proteins are not highly expressed
in healthy tissues other than bone, except during inﬂammation and
wound healing11. SPARC has also been shown to be highly expressed
in cartilage from OA and rheumatoid arthritis (RA) joints13. Osteo-
calcin (OCL) is produced by osteoblasts and is an acknowledgedublished by Elsevier Ltd. All rights reserved.
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ponectin secretion14,15. Whereas OCL is recognized as a bonemarker,
OPN and SPARC are in the setting of an acute knee injury presumably
produced by several cell types. The reasonwhywe analyzedOPN and
SPARC in SF was because of their known multi-functionality. On the
one hand, they are active in bone formation/degradation. On the
other hand, they may induce MMP expression and work as pro-
inﬂammatory agents11,12,16e18. Hence, the release of these markers
into the SF after acute knee injury could contribute to the pro-
inﬂammatory response and turnover of bone and cartilage after the
injury.
Using SF collected from injured knees, the aim of this cross-
sectional study was: (1) to investigate the release of cartilage
biomarkers (sulfated glycosaminoglycan e sGAG and ARGS-
aggrecan), bone biomarkers (OCL, SPARC and OPN) and pro-
inﬂammatory cytokines [interleukin (IL)-1b, IL-6, IL-8 and tumor
necrosis factor (TNF-a)] within 1 month after acute knee injury;
(2) to compare these with SF concentrations from knee-healthy
reference subject; (3) to investigate differences in concentrations
with regard to time from injury to aspiration and (4) to
correlate concentrations of cartilage and bone markers, and pro-
inﬂammatory cytokines.
Materials and methods
Subjects
“During the recruitment process of a randomized controlled
trial (RCT) (ISRCTN 84752559, http://www.controlled-trials.com)19,
we identiﬁed individuals with all types of acute rotational knee
injury. Emergency roomphysicians were instructed to evacuate and
store any hemarthrosis collected from individuals suffering from
acute knee injury, however, all screened patients were not assessed
for inclusion in the RCT due to reasons that could be determined by
reading the medical chart (such as previous knee injury, too young
or too old, not presenting clinical signs of ACL injury etc.). The
recruitment process of the RCT was thoroughly described in
previous publications19,20. In the present studywe have included SF
samples from patients not included in the RCT and also from
patients where hemarthrosis was collected right before or after the
actual start/end of the RCT recruitment process. Altogether we
identiﬁed 114 individuals with acute knee injury that were
included in the present study”. SF was aspirated once, at various
time-points after the knee injury (0e23 days) from each injured
knee, centrifuged at 3000g for 10 min at room temperature and
the supernatant was stored at 80C. Also, SF samples of 10 knee-
healthy subjects, matched to the injured subjects for age and
gender, were included in the study (Table I). Neat SF referenceTable I
Characteristics of the study subjects. For analysis of the biomarker concentrations
in SF as a function of time after injury, the subjects were divided into ﬁve groups.
When SF was collected on the same day as the injury, the SF was deﬁned as having
been collected on day 0. Sixteen patients had history of previous injury/pathology
to the injured knee. Reference subjects; age and gender-matched knee-healthy
subjects
Study groups
Sub-groups
N N (%) women Age in years,
median (range)
Days from injury
to SF aspiration,
median
Reference subjects 10 2 (20) 25 (16e47) e
Injured 0e23 days 111 28 (22) 25 (13e64) 1
0 day 29 7 (24) 30 (14e47) 0
1 day 31 5 (16) 22 (13e42) 1
2e3 days 19 7 (37) 30 (16e48) 3
4e7 days 20 7 (35) 25 (14e64) 6
8e23 days 12 2 (17) 21 (15e25) 10samples were obtained from knee-healthy volunteers without
history of knee symptoms or knee injury, or from patients with
non-speciﬁc knee symptoms and normal ﬁndings on clinical
examination, arthroscopy and plain radiography. None of the SFs
were obtained using a lavage. These reference samples were ob-
tained and used in the course of previous cross-sectional studies on
SF biomarkers:5,6,21,22. All subjects consented to participation in
this trial and the study was approved by the ethical board at Lund
University. Only patients with joint swelling and veriﬁed blood in
the SF (i.e., hemarthrosis), indicative of a signiﬁcant joint trauma,
were included.
sGAG
SF sGAG was measured by Alcian blue precipitation as previ-
ously described23,24. We failed to obtain sGAG concentrations from
seven subjects due to that the Alcian blue precipitates could not be
dissolved. SF was diluted in a range from 1:1 to 1:16 for the sGAG
analysis. Inter assay coefﬁcient of variation (CV) was 5% whereas
the intra assay CV was 2% (n ¼ 5). The concentration of standards
(chondroitin sulfate, Sigma #C4384) ranged from 3 to 200 mg/ml.
ARGS-aggrecan
SF aggrecan ARGS neoepitope, from aggrecanase cleavage at
TEGE392Y393ARGS, was quantiﬁed using electrochemiluminescence
(ECLC) immunoassay as described previously25. Brieﬂy, SF was
deglycosylated for 3 h at 37C with chondroitinase ABC, keratanase
and keratanase II. High-bind MA600 96-well microtiter plates
[#L11XB-1 Meso Scale Discovery (MSD) Gaithersburg, MD, USA]
were coated with an antibody toward the G1 and G2 globular
domains of human aggrecan (#AHP0022, Invitrogen). ARGS-
aggrecan was detected by a biotinylated monoclonal antibody
(MAb OA-1) speciﬁc for the ARGS neoepitope24,26 and incubated
with sulfo-tagged streptavidin (MSD) before red in a Sector Imager
6000 (MSD). SF was diluted in a range from 1:13 to 1:1024 for the
ARGS analysis. Inter assay CV was 22% (n ¼ 7) whereas the intra
assay CV was 4% (n ¼ 5). The concentration of standards ranged
from 0.017 to 6 pmol ARGS/ml.
Bone markers and cytokines
Quantiﬁcation of bone markers (OCL, SPARC and OPN) in SF was
conducted using the multiplex Human Bone Panel II ECLC immu-
noassay (#K11147C MSD) according to the manufacturer. Quanti-
ﬁcation of pro-inﬂammatory cytokines IL-1b, IL-6, IL-8 and TNF-a in
SF was conducted using the multiplex Human Pro-inﬂammatory II
4-Plex Ultra-Sensitive ECLC immunoassay (#K11025C MSD)
according to the manufacturer.
Hyase-treatment, including heating of the SF at 60C for 3 h,
before the pro-inﬂammatory and bone marker assays gave
a marked reduction in the detected concentrations of IL-1b, TNF-a
and SPARC markers (also of the concentrations of standard
samples) compared to analysis without pre-treatment (data not
shown). On the other hand, the SF concentrations of IL-6, IL-8, OCL
and OPN were unaffected by hyase-treatment (no heating effect).
Therefore, all cytokine and bone marker analyses were conducted
without hyase-treatment.
Dilution linearity and spiking recovery
Analysis of dilution linearity is expressed as % recovery:
100 (concentration at a speciﬁc dilution divided by the mean
concentration of all dilutions). Spiking recovery is expressed in % as
recovery: 100 [(signal of a sample spikedwith a speciﬁc amount of
Table II
Comparison of SF biomarkers in acute knee injury and in reference subjects. The
median (range) concentrations of SF cytokines, cartilage and bone biomarkers in
patients with an acute knee injury (sampling between 0 and 23 days after injury,
n ¼ 111) and in knee-healthy reference subjects (n ¼ 10) was analyzed. Italic
numbers; set values equal to the half of the minimum detection limit
Biomarker Acute knee injury References P-value
sGAG (mg/ml) 159.7 (3.0e973.3) 63.6 (31e210) 0.06
ARGS (pmol/ml) 67.3 (1.5e686.4) 7.8 (1.7e19.5) <0.001
OCL (ng/ml) 36.1 (10.3e175.7) 36.8 (18.6e56.8) 0.99
SPARC (ng/ml) 464.8 (76.3e3880.1) 78.9 (42.7e134.5) <0.001
OPN (ng/ml) 46.9 (1.6e920.1) 1.6 (1.6e6.8) <0.001
IL-1b (pg/ml) 10.9 (0.3e135.2) 0.4 (0.1e4.4) <0.001
IL-6 (pg/ml) 3386.4 (17.4e66099.5) 2.1 (0.1e503.9) <0.001
IL-8 (pg/ml) 163.1 (4.6e30574.8) 21.4 (2.1e421.9) <0.001
TNF-a (pg/ml) 8.7 (1.2e47.6) 1.4 (0.4e9.8) <0.001
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vidual signal from standard)]. For analysis of dilution linearity and
spiking recovery a number of randomly selected knee SF samples
were analyzed for each biomarker. A detailed description of the
technical performance of the bone marker and pro-inﬂammatory
cytokine assays is presented as Supplementary data (Table S1e4).
Statistics
For statistical analyses the Statistical Package for Social Sciences
(SPSS, version 17) was used.When the concentration of a biomarker
was below detection limit, the value was set equal to the half of the
value of the minimum detection limit. Between groups differences
(injured vs knee-healthy references) were made using the Manne
Whitney rank sum test [median (range)]. SF biomarker concentra-
tions were not normally distributed and were thus ﬁt to log 10
before analysis of time-dependent changes. Data for the analysis of
time-dependent changes is presented as group means (95% conﬁ-
dence interval e CI). All tests were two-tailed with a P-value <0.05
considered statistically signiﬁcant. Correlations were made using
the Pearson partial correlation coefﬁcient (r) and were adjusted for
age, gender, and time (days) between injury and SF aspiration.
For analysis of the differences in SF biomarker concentrations
with regard to time from injury to aspiration, the subjects were
divided into ﬁve subgroups using the number of days between
injury and aspiration as a variable. The aim was to have approxi-
mately 20 subjects in each group to achieve comparable numbers of
individuals in each group and was done as follows: day 0 (injury
and aspiration the same day, n ¼ 29), day 1 (n ¼ 31), day 2e3
(n ¼ 19), day 4e7 (n ¼ 20) and day 8e23 (n ¼ 12).
Results
Subject inclusion
Of the 114 knees available for the knee injured group, three did
not have a veriﬁed hemarthrosis and were excluded (Table I). The
remaining patients (111) all had veriﬁed hemarthrosis with the
following clinical diagnosis received on discharge from the emer-
gency room: 57 ACL tears (10 with associated partial or total medial
collateral ligament (MCL) tears, three with associated medial
meniscus injury, two with associated lateral meniscus injury, and
one with a ‘give way’ caused by a chronic ACL tear); three medial
meniscus injuries (one with an associated MCL tear); one posterior
cruciate ligament tear (associated with an MCL tear); ﬁve patellar
dislocations (onewith an associatedMCL tear); one had a suspected
tibial fracture; three MCL tears and two lateral collateral ligament
tears. In 39 patients there was no speciﬁed diagnosis: 35 were
determined as rotational knee trauma; three as knee contusion;
one as knee hyperextension. Fifteen knees had a history of previous
injury (mean 5 years prior to the present knee injury), and of these
seven had undergone previous knee surgery. One knee had
a history of chondromalacia patellae. A sensitivity analysis
excluding SF from these 16 knees showed similar mean log 10
[standard deviation (SD)] concentrations of all analyzed
biomarkers when compared to all study subjects (data not shown).
Thus, SF of these knees was included in the analyses resulting in
a total of 111 SF samples from acutely injured knees and 10 SF
samples of age and gender-matched healthy reference knees
included in the study (Table I).
Technical performance
The technical performance of the bonemarkers and cytokines in
SF analyzed by ECLC was in terms of spiking recovery and dilutionlinearity similar to that reported for serum samples by the manu-
facturer (MSD, see supplementary data Table S1e4). The technical
performance of the SF ARGS ECLC immunoassay was similar to
previous ﬁndings25.
Injured knees vs healthy controls
With the exception of OCL (P ¼ 0.992) and sGAG (P ¼ 0.06), SF
biomarker concentrations of bone and cartilage were signiﬁcantly
higher after acute knee injury than in healthy reference subjects’
knees. All cytokine concentrations were higher in acutely injured
knees than in healthy reference knees with the highest SF
concentrations being 1600 times higher (IL-6) and the lowest ﬁve
times higher (TNF-a) in acutely injured knees compared to healthy
reference knees (Table II).
Time between injury and aspiration
Cartilage markers
Compared to concentrations of healthy reference subjects,
ARGS-aggrecan concentrations were signiﬁcantly higher in knees
aspirated 1e23 days after injury, but not in knees aspirated the
same day as injury. sGAG concentrations were higher in knees
aspirated day 2e23, but not the days before. Two to three days after
injury, the sGAG (geometric mean) concentration was ﬁve times
higher and the SF ARGS was 23 times higher than the SF concen-
trations of healthy reference knees (Fig. 1).
Bone markers
No difference in OCL concentrations was found between injured
knees and knees of healthy reference subjects in the time-depen-
dent analysis [Fig. 2(A)]. Concentrations of SPARC and OPN,
however, were signiﬁcantly higher in knees injured and aspirated
on the same day and at all later time-points [Fig. 2(B and C)]. SPARC
concentrations (geometric mean) in injured knees were 4e7.5
times higher than in healthy reference knees at all investigated
time-points [Fig. 2(B)]. OPN concentrations however, were higher
with longer time between knee injury and SF aspiration. The
highest OPN concentrations were detected in patients aspirated
8e23 days after injury with 110 times the concentrations of healthy
reference knees [Fig. 2(C)].
Pro-inﬂammatory cytokines
Except for IL-8 concentrations in knees aspirated 8e23 days
after knee injury, the pro-inﬂammatory cytokine concentrations
were signiﬁcantly higher at all time-points investigated compared
to the concentrations of reference subjects (Fig. 3). All cytokines
displayed a similar pattern in the time-dependent analysis with
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as injury compared to healthy reference knees. In injured knees,
cytokine concentrations were highest in knees aspirated the day
after injury (day 1) and lower with increased time between injury
and aspiration at time-points thereafter (Fig. 3). The concentration
(geometric mean) of IL-1b was 70-times, IL-6 4000-times, IL-8
14-times and TNF-a 8-times higher in knees aspirated 1 day after
knee injury as compared to the corresponding SF cytokine
concentrations of healthy reference knees.
The original data for all analyzed markers is shown as scatter
graphs in the Supplementary (Fig. S1).
Correlations between biomarkers
After adjusting for age, gender, and time between injury (days)
and SF aspiration, there was a strong positive correlation between
the cartilage markers (i.e., sGAG and ARGS-aggrecan, (r ¼ 0.86), and
between OPN and the cartilage markers (sGAG, r ¼ 0.61 and ARGS,
r¼ 0.59) (Table III)). Furthermore,moderate correlationswere found
between SPARC and OCL (r ¼ 0.31) and between SPARC and OPN
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Table III
Correlation of cartilage and bone markers and cytokines in the SF after acute
knee injury. For correlation analysis, Pearson partial correlation coefﬁcient (r) was
used. The values were ﬁt to log 10 before analysis. The analysis was adjusted for age
at injury, gender and days after the injury the SF was collected. The signiﬁcance level
was set at P < 0.01, which here represents a correlation coefﬁcient of r > 0.25.
Signiﬁcant correlations are bolded
sGAG ARGS OCL SPARC
ARGS 0.86
OCL 0.03 0.14
SPARC 0.09 0.13 0.31
OPN 0.61 0.59 0.16 0.29
IL-1 IL-6 IL-8 TNF-a
sGAG 0.22 0.22 0.13 0.14
ARGS 0.11 0.09 0.11 0.04
OCL 0.02 0.03 0.09 0.12
SPARC 0.39 0.34 0.45 0.53
OPN 0.23 0.24 0.16 0.06
P. Swärd et al. / Osteoarthritis and Cartilage 20 (2012) 1302e13081306(r ¼ 0.29), but not between OCL and OPN (r ¼ 0.16). Interestingly,
there were also moderate correlations between SPARC and all the
measured cytokines IL-1b, IL-6, IL-8 and TNF-a (r  0.34, Table III).
Discussion
This is to our knowledge the ﬁrst investigation of cartilage and
bone markers and pro-inﬂammatory cytokines in SF collected
within 1 month of an acute knee injury with a veriﬁed hemarth-
rosis. SF concentrations of ARGS, SPARC, OPN, and all cytokines, but
not sGAG or OCL, were higher in injured knees compared to knees
of age and gender-matched reference subjects. In a separate anal-
ysis, where time between injury and SF aspiration was accounted
for, we found that the SF concentrations of ARGS and sGAG showed
a similar pattern in the time-dependent analysis with higher
concentrations in knees aspirated 1e3 days after injury and
thereafter, but not in those injured and aspirated the same day
(ARGS), or the same day and day 1 after injury (sGAG), compared to
healthy reference knees. Biomarkers of bone formation (SPARC),
bone resorption (OPN) and inﬂammation were however higher in
acutely injured knees than in healthy control knees at all investi-
gated time-points over the ﬁrst 23 days after injury.
Aggrecan is by far the most sGAG substituted proteoglycan in
cartilage27. Therefore, measuring sGAG in SF using the Alcian blue
precipitation method is a valid estimate of the proportion of
aggrecan fragments released into the SF. Our results indicate that
accelerated degradation of aggrecan may not be initiated imme-
diately after a knee trauma but rather 1 day after the injury, when
SF ARGS is higher than in reference knees. In in vitro studies of
bovine cartilage explants, release of aggrecan into the media has
been shown 5 days after IL-1b or TNF-a treatment28. Others have
shown elevated SF concentrations of proteoglycan fragments
including ARGS fragments at various phases fromwithin 1 week up
to years after knee injury, suggesting that cartilage breakdown is
sustained after the acute injury phase5e7,29.
Reports of bone markers released into the SF within days to
weeks after knee injuries are scarce. It was however recently shown
that SF levels of the bone resorption marker NTX-I (N-terminal
telopeptides of type I collagen) increased between 15 and 48 days
after ACL injury30. In addition, bone sialoprotein II (BSP, another
protein of the matricellular protein family), has been shown to be
elevated in the SF of knees with ACL tear or meniscus lesion from
0 to 2 weeks up to 6 months after injury31. The bone marker OCL is
considered to be a speciﬁc marker of osteoblast activity although it
has also been shown to increase in serum during bone resorption32.
Based on the assumption that a knee injury with hemarthrosis in
some cases may include bone fractures10, we expected increased
P. Swärd et al. / Osteoarthritis and Cartilage 20 (2012) 1302e1308 1307OCL concentrations in SF of the acutely injured knees of this study,
partly as a marker of bone resorption but mainly as a marker of
activation of intra-osseous osteoblasts. This assumption was made
although a recent study did not show any signiﬁcant changes in SF
OCL between 15 and 48 days after ACL injury30. We neither could
detect such increase within the ﬁrst 23 days after injury in this
cross-sectional study, despite the large sample size and the early
aspiration of hemarthrosis.
SF concentrations of the bone markers SPARC (involved in the
synthesis and assembly of type I collagen in bone) and OPN
(secreted by immature and mature osteoblasts and believed to
regulate matrix mineralization and to be essential for resorption of
bone by osteoclasts)11,17, were higher in acutely injured knees than
in healthy reference knees in this study. These proteins are known to
be released by several cell types, including endothelial cells and
macrophages, in response to tissue injury. This could explain the
observed increase in SF concentrations of these markers aspirated as
early as the same day as the injury. On the other hand, it may reﬂect
a direct release of these markers from the injured bone matrix as
a consequence of severe impaction forces applied to the subchondral
bone at the time of injury. Further, the increase in SF concentrations
of OPN over time observed in our study could be related to
increasing degradation of bone matrix with time after the injury.
It has been hypothesized that an early inﬂammatory response
after severe knee injury (ACL injury) could lead to irreversible
structural cartilage damage, and efforts toward inhibiting the joint
inﬂammation, are underway30,33. Hence, detailed information of
the early inﬂammatory response in vivo following an acute knee
injury is of importance to gain insight into the different time-points
after joint injury and the treatment that may be indicated. The
acute phase of severe knee injury commonly involves joint swelling
mainly due to hemarthrosis and also increased SF concentrations of
pro-inﬂammatory cytokines, released from the joint tissues after
the trauma33,34. A previous investigation of 34 ACL injured indi-
viduals showed higher SF concentrations of pro-inﬂammatory
cytokines compared to a control group of chronic arthritis
patients, and that these concentrations decreased from the day of
injury to 3 weeks after the injury9. Our results conﬁrm these
ﬁndings in a larger sample, however, our more detailed time-
dependent analysis also showed that all cytokine concentrations,
and particularly IL-1b and IL-6 were higher in knees aspirated 1 day
after injury than in knees aspirated and injured the same day. This
suggests that the maximal inﬂammatory response after knee injury
with hemarthrosis may not be immediate as opposed to what has
been observed in a mouse model of skin tissue injury where pro-
inﬂammatory cytokine concentrations in wound tissue ﬂuid
peaked 3e12 h after injury. In that study IL-1b and TNF-a peaked
after 3 h and IL-6 after 12 h35. This w24 h delay in maximum
inﬂammatory response may be of clinical importance when inter-
ventions toward inhibiting the initial inﬂammation are considered.
Our investigation suggests that SPARC and OPN concentrations
may increase already the same day as knee injury and that OPN
concentrations seem to further increase with longer time from
injury, at least within the ﬁrst 23 days from injury. OPN concen-
trations may also be related to both sGAG and ARGS concentrations
in SF after an acute knee injury. Cytokine concentrations on the
other hand, showed the highest concentrations 1 day after injury
and were lower, but still higher than in healthy reference knees, at
later time-points after injury. Since OPN is known to have pro-
inﬂammatory abilities17,36,37 and SPARC correlated moderately to
levels of pro-inﬂammatory cytokines in this study, we hypothesize
that OPN and SPARC, normally not found in abundance in other
tissues than bone, may cause prolonged inﬂammation in the
acutely injured joint. Considering the increasing body of evidence
suggesting that inﬂammation is involved in the OA process, andspeciﬁcally post-traumatic OA development34, we suggest that this
hypothesis should be further tested.
This study has certain limitations. First, the design precludes
ﬁrm conclusions of trends in time as no repeated sampling was
made within the individuals. Hence, our suggestions on differences
in biomarker concentrations over time need to be conﬁrmed in
other longitudinal studies. Secondly, some knees in the acutely
injured group were previously injured, the age of the sample was
heterogeneous and we did not control for possible OA of the aspi-
rated joint. Strengths of this study include the relatively large
sample size, the narrow period between aspiration and knee injury
and the fact that all knees had a veriﬁed traumatic hemarthrosis.
In conclusion, this cross-sectional study suggests that an acute
knee injury is associated with instant and sustained SF biochemical
alterations directly after the trauma. Compared to knees of age and
gender-matched healthy reference subjects, acutely injured knees
with hemarthrosis have elevated SF concentrations of the cartilage
biomarker ARGS, bone biomarkers SPARC and OPN and the pro-
inﬂammatory cytokines IL-1b, IL-6, IL-8 and TNF-a. Furthermore,
there could be large variations in these concentrations within the
ﬁrst month of injury and there may be a relation between OPN and
cartilage markers and between SPARC and pro-inﬂammatory
cytokines. In the future, to conﬁrm our results, a longitudinal
study needs to be performed.
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